A5057993575- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Management and Research
- Diabetes Treatment and Management
- Antibiotic Use and Resistance
- Biosimilars and Bioanalytical Methods
- Computational Drug Discovery Methods
- Inflammasome and immune disorders
- Pharmaceutical Practices and Patient Outcomes
- COVID-19 and Mental Health
- Antibiotic Resistance in Bacteria
- Diabetes and associated disorders
- Vitamin C and Antioxidants Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Management, Economics, and Public Policy
- Legal and Labor Studies
- COVID-19 Impact on Reproduction
- SARS-CoV-2 detection and testing
- Pharmacology and Obesity Treatment
- Pharmaceutical studies and practices
- Potassium and Related Disorders
- Cancer Genomics and Diagnostics
Farmaceutici Damor (Italy)
2023-2024
Institute of Nanotechnology
2024
Istituto di Nanotecnologia
2023-2024
Istituto Nanoscienze
2024
Istituto Nazionale di Fisica Nucleare, Sezione di Napoli
2023
Ministry of Health of the Russian Federation
2023
University of Milan
2023
Ministero della Salute
2023
ASL Roma
2020-2023
Universidad de Costa Rica
2023
In December 2019, the first data emerged from Wuhan, China, of a serious acute respiratory disease caused by new coronavirus, SARS-CoV-2 (COVID-19). short time, health emergency became global pandemic. To date, there are about 18.8 million infected people and 700,000 deaths. There currently no effective vaccines, treatments mostly experimental. The symptoms associated with COVID-19 different, ranging mild upper tract to severe distress syndrome (SARS). Data previous coronavirus outbreaks...
In March 2019 began the global pandemic COVID-19 caused by new Coronavirus SARS-CoV-2. The first cases of SARS-CoV-2 infection occurred in November-19 Wuhan, China. preventive measures taken did not prevent rapid spread virus to all countries around world. To date, there are about 2.54 million deaths, effective vaccines clinical trials. uses ACE-2 protein as an intracellular gateway. is a key component Renin Angiotensin (RAS) system, regulator cardiovascular function. Considering role...